{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:41:01Z","timestamp":1768372861197,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,13]]},"DOI":"10.7759\/cureus.101456","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:20:26Z","timestamp":1768328426000},"source":"Crossref","is-referenced-by-count":0,"title":["Peritoneal Sarcomatosis Secondary to a Gastrointestinal Stromal Tumor Treated With a Multimodal Approach: A Case Report"],"prefix":"10.7759","author":[{"given":"Arleyson Daniel","family":"Perez Zambrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Garcia Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefany","family":"Rios Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231192388","article-title":"2023 GEIS Guidelines for gastrointestinal stromal tumors","volume":"15","author":"Serrano C","year":"2023","unstructured":"Serrano C, Mart\u00edn-Broto J, Asencio-Pascual JM, et al.. 2023 GEIS Guidelines for gastrointestinal stromal tumors. Ther Adv Med Oncol. 2023, 15:17588359231192388. 10.1177\/17588359231192388","journal-title":"Ther Adv Med Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16152646","article-title":"Ibero-American consensus for the management of peritoneal sarcomatosis: updated review and clinical recommendations","volume":"16","author":"Mu\u00f1oz-Casares FC","year":"2024","unstructured":"Mu\u00f1oz-Casares FC, Mart\u00edn-Broto J, Cascales-Campos P, et al.. Ibero-American consensus for the management of peritoneal sarcomatosis: updated review and clinical recommendations. Cancers (Basel). 2024, 16:10.3390\/cancers16152646","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32881","article-title":"The Chicago Consensus on peritoneal surface malignancies: management of appendiceal neoplasms","volume":"126","year":"2020","unstructured":"The Chicago Consensus on peritoneal surface malignancies. management of appendiceal neoplasms. Cancer. 2020, 126:2525-33. 10.1002\/cncr.32881","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1215-5","article-title":"Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report","volume":"11","author":"Fukuda S","year":"2017","unstructured":"Fukuda S, Fujiwara Y, Wakasa T, et al.. Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report. J Med Case Rep. 2017, 11:33. 10.1186\/s13256-017-1215-5","journal-title":"J Med Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-001082","article-title":"Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment","volume":"5","author":"Boil\u00e8ve A","year":"2020","unstructured":"Boil\u00e8ve A, Dufresne A, Chamseddine A, et al.. Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment. ESMO Open. 2020, 5:e001082. 10.1136\/esmoopen-2020-001082","journal-title":"ESMO Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12567-1","article-title":"Survival of advanced\/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study","volume":"24","author":"Tsai HJ","year":"2024","unstructured":"Tsai HJ, Shan YS, Yang CY, et al.. Survival of advanced\/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study. BMC Cancer. 2024, 24:828. 10.1186\/s12885-024-12567-1","journal-title":"BMC Cancer"},{"key":"ref7","article-title":"Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor","volume":"80","author":"Bryan ML","year":"2014","unstructured":"Bryan ML, Fitzgerald NC, Levine EA, Shen P, Stewart JH, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in sarcomatosis from gastrointestinal stromal tumor. Am Surg. 2014, 80:890-5.","journal-title":"Am Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3978-x","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","volume":"22","author":"Helm JH","year":"2015","unstructured":"Helm JH, Miura JT, Glenn JA, et al.. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015, 22:1686-93. 10.1245\/s10434-014-3978-x","journal-title":"Ann Surg Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ciresp.2013.01.014","article-title":"Peritoneal gistosis: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy (Article in Spanish)","volume":"92","author":"Medina Fern\u00e1ndez FJ","year":"2014","unstructured":"Medina Fern\u00e1ndez FJ, Mu\u00f1oz-Casares FC, Arjona-S\u00e1nchez A, Casado-Adam A, Rufi\u00e1n Pe\u00f1a S. Peritoneal gistosis: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy (Article in Spanish). Cir Esp. 2014, 92:289-90. 10.1016\/j.ciresp.2013.01.014","journal-title":"Cir Esp"},{"key":"ref10","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis: long-term outcome from a single institution experience","volume":"33","author":"Sommariva A","year":"2013","unstructured":"Sommariva A, Pasquali S, Del Fiore P, et al.. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis: long-term outcome from a single institution experience. Anticancer Res. 2013, 33:3989-94.","journal-title":"Anticancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4360-8","article-title":"Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS)","volume":"22","author":"Rubi\u00f3-Casadevall J","year":"2015","unstructured":"Rubi\u00f3-Casadevall J, Martinez-Trufero J, Garcia-Albeniz X, et al.. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS). Ann Surg Oncol. 2015, 22:2948-57. 10.1245\/s10434-014-4360-8","journal-title":"Ann Surg Oncol"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.21037\/gist-21-2","article-title":"A narrative review of surgical management of gastrointestinal stromal tumors","volume":"4","author":"Kalinowska I","year":"2021","unstructured":"Kalinowska I, Zdzienicki M, Skoczylas J, Rutkowski P. A narrative review of surgical management of gastrointestinal stromal tumors. Gastrointest Stromal Tumor. 2021, 4:7-10.","journal-title":"Gastrointest Stromal Tumor"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05965-2","article-title":"Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability","volume":"150","author":"Haller V","year":"2024","unstructured":"Haller V, Reiff C, Hamacher R, et al.. Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability. J Cancer Res Clin Oncol. 2024, 150:489. 10.1007\/s00432-024-05965-2","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/444680-peritoneal-sarcomatosis-secondary-to-a-gastrointestinal-stromal-tumor-treated-with-a-multimodal-approach-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:20:26Z","timestamp":1768328426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/444680-peritoneal-sarcomatosis-secondary-to-a-gastrointestinal-stromal-tumor-treated-with-a-multimodal-approach-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.101456","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,13]]}}}